← Open Payments lookup

DEBRA BROWN: Open Payments

NPI 1962609487 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,096 in 13 payments from 7 companies in 2025. Trend: 2023 $660 · 2024 $575 · 2025 $1,096

Food & beverage: $1,096
CompanyPaymentsAmount
Insulet Corporation2$263
Corcept Therapeutics2$240
BETA BIONICS, INC.5$238
Bayer Healthcare Pharmaceuticals Inc.1$120
Lilly USA, LLC1$115
Dexcom, Inc.1$104
AstraZeneca Pharmaceuticals LP1$17

Products named: OMNIPOD, Korlym, iLet Bionic Pancreas, Kerendia, ZEPBOUND, Dexcom G6 Transmitter, FARXIGA.

Industry payments across LA — which companies pay providers there.